Skip to main content
An official website of the United States government

Funded Grants

Grants awarded in the current fiscal year and carried over from prior fiscal years.

PI Name PI Organization Sort descending Title Grant Number Initiative Program Official
Perez-Lougee, Giselle Katiria

Massachusetts General Hospital
United States

Thriving Beyond Treatment: A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship 1R37CA303094-01 Marjorie Perloff, M.D.
Osarogiagbon, Raymond U

Baptist Memorial Hospital - Tipton
United States

Baptist Memorial Health Care/Mid South NCORP Consortium 3UG1CA189873-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Carlson, Jay W

Ozark Health Ventures, Llc
United States

Ozark Health Ventures LLC dba Cancer Research for the Ozarks (CRO) 3UG1CA189822-11S1 Vanessa A. White, M.P.H.
Mustian, Karen M.

University Of Rochester
United States

URCC NCORP Research Base 3UG1CA189961-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Labaer, Joshua

Arizona State University-Tempe Campus
United States

Multiplex In-Solution Protein Array (MISPA) for high throughput, quantitative, early profiling of pathogen-induced head and neck 5R33CA281802-03 Wendy Wang, Ph.D., M.Sc.
Ahn, Jiyoung

New York University School Of Medicine
United States

The Oral Mycobiome and Risk of Pancreatic Cancer 5U01CA250186-04 Claire Zhu, Ph.D.
Sempere, Lorenzo

Michigan State University
United States

Image-Guided Intraductal Ablative Procedure for Primary Prevention of Breast Cancer 5R01CA258314-05 Edward Sauter, M.D., Ph.D.
Ibsen, Stuart Duncan

Oregon Health & Science University
United States

Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers 5R37CA258787-05 Matthew Young, Ph.D.
Meghani, Salimah H.

University Of Pennsylvania
United States

Cannabis use and outcomes in ambulatory patients with cancer: A 12-month cohort study 3R01CA270483-04S1 PA-18-917 (R01 - Clinical Trial Optional) Gabriela Riscuta, M.D., CNS
Rao, Chinthalapally V.

University Of Oklahoma Hlth Sciences Ctr
United States

Discovery and Development of Natural Products for Interception of CRC 5UG3CA290310-02 Kajal Biswas, Ph.D.